09.00-09.05 Welcome & introduction - Harry Janssen

Liver cancer and end-stage liver disease - Chair Caroline den Hoed
9.05 How to optimize liver cancer surveillance - Milan Sonneveld
9.25 Palliative care in liver cirrhosis - Ben Hudson 
9.50 Living-donor liver transplantation, the Erasmus MC experience - Robert Minnee
10.10 Discussion + Q&A

10.30 State of the art: Chronic HBV and delta infection, from suppression to cure? Harry Janssen

11.00 Coffee break

Clinical challenges - Chair Rowan van Golen
11.30 Fontan-associated liver disease: a multidisciplinary challenge - Annemien van den Bosch & Sarwa Darwish Murad
11.55 Adulthood genetic cholestasis: Case and practical approach - Deepak Joshi
12.20 Active IBD and the liver - Palak Trivedi
12.45 Discussion + Q&A

13.00 Lunch

Steatotic liver disease - Chair Sandra Coenen
14.00 Interplay of metabolic dysfunction-associated steatotic liver disease and alcohol-associated liver disease - Aleksander Krag
14.30 MASLD; when to see the internist and when to see the hepatologist - Mesut Savas & Willem Pieter Brouwer
14.50 Newest treatment options for MASLD - Jörn Schattenberg
15.15 Discussion + Q&A

15.30 State of the art: Baveno VIII; what is new? - Annalisa Berzigotti
 

16.00 Closing remarks and drinks - Harry Janssen